Summary
Danaher Corporation (DHR) filed an 8-K on January 8, 2024, to provide a preview of its anticipated financial performance for the fourth quarter of 2023, ahead of its presentation at the J.P. Morgan Healthcare Conference. The filing includes a press release and presentation slides, which are incorporated by reference. Investors should note that this information is furnished and not formally "filed" under Section 18 of the Exchange Act, meaning it does not automatically update previous filings unless explicitly referenced.
Key Highlights
- 1Danaher Corporation (DHR) issued a press release and presentation slides detailing anticipated Q4 2023 financial performance.
- 2The information was shared in advance of the company's participation in the J.P. Morgan Healthcare Conference on January 9, 2024.
- 3The furnished information includes specific financial performance outlook for the fourth quarter of 2023.
- 4The filing incorporates the press release and presentation slides by reference.
- 5Key details regarding Danaher's anticipated financial results for the full year 2023 are also present in the attached presentation slides.
- 6The company emphasizes that this information is furnished under Item 2.02 and is not considered 'filed' for Section 18 purposes unless expressly stated otherwise in a future filing.